For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Intuitive Surgical (ISRG - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Intuitive Surgical is a member of the Medical sector. This group includes 818 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ISRG is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 5.35% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ISRG has returned about 40.35% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 4.93% on average. This means that Intuitive Surgical is performing better than its sector in terms of year-to-date returns.
Looking more specifically, ISRG belongs to the Medical - Instruments industry, a group that includes 92 individual stocks and currently sits at #81 in the Zacks Industry Rank. Stocks in this group have gained about 17.29% so far this year, so ISRG is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to ISRG as it looks to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Intuitive Surgical (ISRG - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Intuitive Surgical is a member of the Medical sector. This group includes 818 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ISRG is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 5.35% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ISRG has returned about 40.35% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 4.93% on average. This means that Intuitive Surgical is performing better than its sector in terms of year-to-date returns.
Looking more specifically, ISRG belongs to the Medical - Instruments industry, a group that includes 92 individual stocks and currently sits at #81 in the Zacks Industry Rank. Stocks in this group have gained about 17.29% so far this year, so ISRG is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to ISRG as it looks to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ISRG - FREE